ARAY - Accuray Inc
IEX Last Trade
2.19
0.010 0.457%
Share volume: 541,374
Last Updated: Fri 30 Aug 2024 09:59:54 PM CEST
Surgical and Medical Instrument Manufacturing :
-0.56%
PREVIOUS CLOSE
CHG
CHG%
$2.18
0.01
0.46%
Fundamental analysis
21%
Profitability
23%
Dept financing
43%
Liquidity
16%
Performance
15%
Performance
5 Days
-4.39%
1 Month
14.14%
3 Months
38.85%
6 Months
-16.48%
1 Year
-23.51%
2 Year
-11.38%
Key data
Stock price
$2.19
DAY RANGE
N/A - N/A
52 WEEK RANGE
$1.40 - $3.10
52 WEEK CHANGE
-$0.25
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/05/2024
Company detail
CEO: Joshua Levine
Region: US
Website: http://www.accuray.com/
Employees: 1,122
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing
Region: US
Website: http://www.accuray.com/
Employees: 1,122
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing
accuray incorporated (nasdaq: aray) is a radiation oncology company that develops, manufactures and sells precise, innovative tumor treatment solutions that set the standard of care with the aim of helping patients live longer, better lives. the company's leading-edge technologies deliver the full range of radiation therapy and radiosurgery treatments. for more information, please visit www.accuray.com. for career opportunities, please visit http://www.accuray.com/careers.
Recent news